FGF-2 expression and its action in human leukemia and lymphoma cell lines

1999; 94: 1086–1099. 6 Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen I-M et al. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 1997; 89: 3323–3329. 7 Calado RT, Falcão RP, Garcia AB, Gabellini SM, Zago MA, Franco RF. Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells. Haematologica 2002; 87: 564–568. 8 Nakayama M, Wada M, Harada T, Nagayama J, Kusaba H, Ohshima K et al. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemia. Blood 1998; 92: 4296–4307.